This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Treat vitamin D deficiency to prevent deadly ... Vitamin D supplements have been found to reduce the risk of ... (13 Jan 2019)
Even moderate alcohol consumption is a risk ... A new study published in HeartRhythm reports that regular ... (13 Jan 2019)
Are Your Facebook Friends Making You Feel ... Research published in Heliyon finds that Facebook users who ... (13 Jan 2019)
High intake of dietary fibre and whole ...   High intake of dietary fibre and whole grains associated ... (13 Jan 2019)
Newborns Face Risks When Born to Women with ... Pregnant women with influenza are more likely to experience ... (11 Jan 2019)
Monday, 14 May 2018 20:18

Osteoporosis Drug May Benefit Heart Health Featured

Rate this item
(0 votes)

The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures. The association was seen for up to 10 years after fracture.

In the study, patients newly diagnosed with hip fracture from 2005 through 2013 were followed until late 2016. Among 34,991 patients, 4602 (13%) received osteoporosis treatment during follow-up.

Alendronate was associated with 67% and 45% lower risks of one-year cardiovascular death and heart attack, respectively. It was associated with an 18% reduced risk of stroke within five years and a 17% reduced risk of stroke within 10 years. Protective effects were not evident for other classes of osteoporosis treatments.

“It is well established that there is a world-wide crisis in the treatment of osteoporosis, due to patients’ awareness of the extremely rare side effects,” said senior author Dr. Ching-Lung Cheung, of the University of Hong Kong. “Our findings show that alendronate is potentially cardioprotective in hip fracture patients. Therefore, physicians should consider prescribing alendronate or other nitrogen-containing bisphosphonates to hip fracture patients soon after their fracture, and patients should also have good compliance with alendronate treatment, as this is not only good for your bones, but also your heart.”

In addition to clinical management, the study also has important implications in clinical trial design of anti-osteoporosis medications. The US Food and Drug Administration recently requested more data before reaching a decision on whether to approve the osteoporosis drug romosozumab, due to excess cardiovascular adverse events in the romosozumab arm compared with the alendronate arm. “In light of these important deliberations, our results suggest that such differences in cardiovascular adverse events could be potentially related to a protective association of alendronate, rather than an increase in cardiovascular adverse events related to romosozumab use, said Dr. Cheung.”


Source: Wiley
Full bibliographic information

Chor-Wing Sing, Angel YS Wong, Douglas P Kiel, Elaine YN Cheung, Joanne KY Lam, Tommy T Cheung, Esther W Chan, Annie WC Kung, Ian CK Wong and Ching-Lung Cheung. Association of Alendronate and Risk of Cardiovascular Events in Patients With Hip Fracture. Journal of Bone and Mineral Research. DOI: 10.1002/jbmr.3448. 

Read 434 times Last modified on Tuesday, 15 May 2018 18:30

Latest news

Highlights

  • CLINICS AVAILABLE AT RATIONAL PHARMACY

    CLINICS AVAILABLE  AT RATIONAL PHARMACY , VALLEY ROAD,  B'KARA FOR CONSULTANTS .  GENERAL PRACTITIONER REQUIRED MORNINGS AND AFTERNOONS.

    Written on November 19, 2018
  • WASP - Writing A Scientific Paper

    Quantitative Statistical Analysis
    3-5th April 2019 @ Malta Life Sciences Park
    San Gwann, Malta
    Endorsed by EBCOG and MIPS

    The Write a Scientific Paper (WASP) is an intensive 3 day course that covers all aspects pertaining to writing a scientific paper: from proposal to data protection, data gathering, analysis, writing, dealing with editors and presenting one's research. WASP's uniqueness is its breadth, particularly the statistical analysis sections which are explained in an extremely simple manner.

    Written on December 21, 2018 Read more...

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…